This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Study Offers New Recommendations for TB Vaccine Testing in Humans
    When results from a landmark tuberculosis vaccine trial in Cape Town, South Africa were published in The Lancet in February 2013, the headlines were grim, despite hopes that the trial would point toward a successful way to thwart one of the globe’s biggest public ...More
    November 12, 2015 Posted in News
  • Study Reveals Structure of Tuberculosis Enzyme, Could Offer Drug Target
    A team of scientists, including several from the U.S. Department of Energy’s Argonne National Laboratory, have determined the structures of several important tuberculosis enzymes, which could lead to new drugs for the disease. ...More
    November 2, 2015 Posted in News
  • TB Ranks Alongside HIV as a Leading Cause of Death Worldwide, WHO Report Says
    The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization ...More
    October 28, 2015 Posted in News
  • Stopping Tuberculosis Requires a New Strategy, Researchers Say
    Unless there is a major shift in the way the world fights tuberculosis--from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions--the epidemic and drug resistance will worsen, say researchers at Harvard T.H. Chan ...More
    October 26, 2015 Posted in News
  • Tulane Researchers Working on New Tuberculosis Vaccine
    Researchers at the Tulane National Primate Research Center (TNPRC) are leading efforts to find a new vaccine for tuberculosis, one of the world’s deadliest diseases. Tuberculosis, a contagious infection of the lungs, affected more than 9 million people in 2013, ...More
    October 14, 2015 Posted in News
  • TTUHSC El Paso to Research TB Vaccine
    A $375,000 grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation was awarded to Subramanian Dhandayuthapani, PhD, an associate professor in the Center of Emphasis in Infectious Diseases at the Texas Tech University Health Sciences Center (TTUHSC) El Paso Paul ...More
    September 23, 2015 Posted in News
  • Electronic Reminders Can Help Tuberculosis Patients Stay on Medication
    Reminders to take medication, delivered to patients via an electronic pillbox, may be able to improve adherence to tuberculosis (TB) treatment. The findings, reported this week in PLOS Medicine, are the result of a cluster randomized controlled trial by Shiwen Jiang of the ...More
    September 15, 2015 Posted in News
  • Review of Animal Studies Questions Effects of MVA85A Vaccine on Tuberculosis
    A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children. The new vaccine was a virus-expressing antigen 85A (MVA85A) designed to boost the immunity ...More
    September 9, 2015 Posted in News
  • Rapid TB Testing Aims to Reduce Drug Resistance, Lower Mortality Rate
    Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a ...More
    September 8, 2015 Posted in News